Fs-laser safe for capsulotomy creation

Article

Anterior capsulotomies may be created safely and efficaciously using a femtosecond laser system (Catalys Precision Laser System, Abbott Medical Optics), according to a study published online in the Journal of Cataract & Refractive Surgery.

Anterior capsulotomies may be created safely and efficaciously using a femtosecond laser system (Catalys Precision Laser System, Abbott Medical Optics), according to a study published online in the Journal of Cataract & Refractive Surgery.

Researchers from Moorfields Eye Hospital, London, conducted a prospective consecutive case series that evaluated 1,000 femtosecond laser–assisted cataract cases performed at the hospital between January 2013 and March 2014. During that time, platform software versions 2.15, 2.15.13, and 2.20 of the femtosecond laser system were used. The researchers evaluated the rate of complete capsulotomies that were performed without adhesions and anterior capsule tears.

The researchers found that in 998 of the 1,000 cases (99.8%), a complete 360-degree capsulotomy was present without adhesions or bridging tags. There were no cases of intraoperative tears of the anterior capsule.

There were 2 cases of incomplete capsulotomy: 1 in which the laser was aborted during the procedure and the procedure was completed manually, and 1 in which a single bridging tag adhesion occurred at capsulotomy removal, and a radial tear was identified after removal of the nucleus. The tear did not extend to the posterior capsule.

To read the abstract of the study, click here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.